Roger J. Lias
2019
Compensation breakdown
| Non-Equity Incentive Plan | $188,760 |
|---|---|
| Option Awards | $116,890 |
| Salary | $463,185 |
| Other | $110,842 |
| Total | $879,677 |
Lias received $463.2K in salary, accounting for 53% of the total pay in 2019.
Lias also received $188.8K in non-equity incentive plan, $116.9K in option awards and $110.8K in other compensation.
Rankings
In 2019, Roger J. Lias' compensation ranked 9,839th out of 13,971 executives tracked by ExecPay. In other words, Lias earned more than 29.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,839 out of 13,971 | 30th |
Division Manufacturing | 3,975 out of 5,701 | 30th |
Major group Chemicals And Allied Products | 1,516 out of 2,200 | 31st |
Industry group Drugs | 1,296 out of 1,886 | 31st |
Industry Pharmaceutical Preparations | 963 out of 1,398 | 31st |
Pay ratio
| Roger J. Lias' Pay | $879,677 |
|---|---|
| Median Employee's Pay | $96,570 |
| Pay Ratio | 9to 1 |
In 2019, the annual total compensation of Roger J. Lias was $879,677.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $96,570.
The ratio of Roger J. Lias' pay to the pay of median employee was therefore 9 to one.
Lias' colleagues
We found four more compensation records of executives who worked with Roger J. Lias at Peregrine Pharmaceuticals in 2019.
2019
Daniel Hart
Peregrine Pharmaceuticals
Chief Financial Officer
2019
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
2019
Stephen Hedberg
Peregrine Pharmaceuticals
Principal Financial Officer and Principal Accounting Officer
2019
Paul Lytle
Peregrine Pharmaceuticals